Comparative effectiveness and safety of non-VKA oral anticoagulants versus warfarin in non-valvular atrial fibrillation patients with differential treatment duration: an ARISTOPHANES study analysis
2 September 2019 (14:00 - 18:00)
Organised by:
Abstract
Slides
About the speaker
Bristol Myers Squibb, Princeton (United States of America)
9 More presentations in this session
Access the full session
The Event
ESC Congress 2019
2 September 2019
14:00 CET
You may be interested in
Congress Session
Congress Session
